company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1948000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1948000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,254000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,385000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,181000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7481000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4713000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4713000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-85000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-17906000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-3000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,18205000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,211000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,211000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,706000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-12684000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-715000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-12690000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-12690000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1954000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15238000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6314000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6314000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,246000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,363000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,377000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6971000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1643000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1643000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-88000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-28118000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7367000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,5000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,37900000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-14900000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12568000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12568000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1044000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,12079000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,715000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,11753000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,11753000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,5643000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6471000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q4,2010-10-01,2010-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2010.0,Q4,2010-10-01,2010-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2683000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:20:49+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6909000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:20:49+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6909000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:20:49+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,249000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:20:49+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,292000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:20:49+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,715000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:20:49+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-394000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:20:49+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6047000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:20:49+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6047000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:20:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-133000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:20:49+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-3000000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:20:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8790000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:20:49+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16583000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:20:49+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4660000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:20:49+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4660000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:20:49+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:20:49+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:20:49+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:20:49+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:20:49+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:20:49+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,499000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:20:49+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-885000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9019000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9019000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,401000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,292000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,948000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-961000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8339000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8339000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-47000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3992000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13105000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9066000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9066000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,98000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,101000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,101000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3093000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3921000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4078000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4078000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,376000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,16000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-6792000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7785000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2693000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2693000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7670000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-149000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-147000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-147000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1842000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2988000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2700000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2700000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,282000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,51000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-21009000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,15064000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2912000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2912000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6505000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-7500000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-551000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,8000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-8038000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-8038000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-160000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4605000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,171000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:51:51+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1928000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1928000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,350000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,31000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2109000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4245000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:51:51+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4807000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:51:51+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4807000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-40000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-3000000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-432000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5750000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:51:51+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2278000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:51:51+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2278000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,44000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:51:51+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,51000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:51:51+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,51000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:51:51+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2294000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 16:51:51+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4842000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-819000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-819000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,381000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,18000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,23879000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-27498000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4039000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4039000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-225000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1998000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12392000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-432000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9737000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9735000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,23000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,27000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,27000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,464000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6187000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5949000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5949000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,374000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1105000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1466000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5936000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5936000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-41000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3501000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6953000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1364000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2047000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2051000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-556000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-552000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-552000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-8000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4445000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,13532000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13532000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,383000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,18000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-214000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3449000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,17168000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,17168000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-133000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-17678000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3445000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-285000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-14651000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-14653000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-7500000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-721000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,244000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-7972000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-7972000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,233000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5224000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,157000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:51+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3145000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3145000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,381000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,27000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-420000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2482000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:51+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5639000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:51+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5639000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-120000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1699000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3360000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-9487000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:51+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7946000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:51+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7946000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-335000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,10600000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:51+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:51+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,10270000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:51+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,10270000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:51+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-64000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:51+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3379000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6119000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6119000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,372000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,26000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-232000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6548000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-263000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-263000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-700000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1700000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-540000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,440000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,440000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3725000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1857000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1863000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1863000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,331000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1355000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1292000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1292000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,364000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,28000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,732000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4692000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2276000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2276000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5511000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,700000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-4000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4828000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4828000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-10000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-269000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7377000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2749000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2749000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,371000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,29000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,314000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,506000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3969000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3969000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2217000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1480000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,470000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-282000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-282000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3814000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5289000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,703000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2178000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2178000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1674000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4191000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,156000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 15:14:46+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,675000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 15:14:46+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,675000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 15:14:46+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-361000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 15:14:46+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,26000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 15:14:46+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-270000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 15:14:46+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3491000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 15:14:46+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3561000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 15:14:46+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3561000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 15:14:46+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-41000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 15:14:46+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1950000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 15:14:46+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1909000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 15:14:46+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1909000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 15:14:46+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5332000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 15:14:46+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1134000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 15:14:46+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6466000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 15:14:46+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6466000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 15:14:46+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,104000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 15:14:46+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,12040000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1691000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1691000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1082000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,24000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1758000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4021000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,534000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,534000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4515000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4250000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-273000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-273000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3906000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,972000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2926000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2926000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,55000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2610000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1480000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1480000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,263000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,19000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7797000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6122000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3437000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3437000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7709000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7250000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-472000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-472000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,1000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-36000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-25000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-25000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-385000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2555000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,9282000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9282000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,106000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,13000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,483000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,13462000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,23346000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,23346000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-16929000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2900000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,25828000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,11795000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,11795000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-20999000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,12000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2059000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-18928000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-18928000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-678000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,15535000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,129000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:15:08+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6408000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:15:08+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6408000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:15:08+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,83000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:15:08+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,26000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:15:08+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1093000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:15:08+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3031000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:15:08+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4579000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:15:08+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4579000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:15:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:15:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-25987000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:15:08+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5250000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:15:08+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:15:08+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-20749000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:15:08+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-20749000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:15:08+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:15:08+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,11000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:15:08+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4139000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:15:08+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4150000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:15:08+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4150000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:15:08+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,37000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:15:08+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11983000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,9576000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9576000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,132000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,50000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,736000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,11000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10505000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10505000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-35000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-13788000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16569000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2000000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4746000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4746000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4077000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,27000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,600000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3450000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3450000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-97000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11704000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7236000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7236000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,218000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,45000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2078000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-456000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,9121000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,9121000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1976000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10633000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,548000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9205000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9205000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,36000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1690000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1726000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1726000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,110000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,20162000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,10151000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10151000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,10147000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-4567000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-21351000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5620000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5620000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3414000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-161187000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,43164000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2916000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-124353000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-124353000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4159000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-43956000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,235911000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,54000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-40935000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,146915000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,146915000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-163000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16779000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,5983000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:43+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4057000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:43+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4057000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:43+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15573000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:43+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6197000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:43+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6024000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:43+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,23737000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:43+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,23737000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:43+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-735000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:43+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2615000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:43+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3350000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:43+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3350000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:43+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-17574000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:43+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,58000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:43+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,18433000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:43+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,917000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:43+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,917000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:43+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,489000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:43+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,21793000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-832000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-832000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14525000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6702000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-17847000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2548000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2548000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-88000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,545000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,457000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,457000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-12508000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,70000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,886000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-11552000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-11552000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,6451000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2096000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,8093000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8093000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7775000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,434000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11839000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4463000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4463000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-396000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-250000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1704000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1058000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1058000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6250000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,46000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,19000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6185000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6185000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1148000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,484000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,15283000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15283000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7810000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6311000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-51839000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22435000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22435000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5000000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,5000000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-233581000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,290495000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,39000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,30400000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,87353000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,87353000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,4932000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,69843000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,20033000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 17:13:43+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4624000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 17:13:43+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4624000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 17:13:43+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7422000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 17:13:43+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2503000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 17:13:43+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,30731000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 17:13:43+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,45280000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 17:13:43+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,45280000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 17:13:43+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-350000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 17:13:43+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 17:13:43+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-350000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 17:13:43+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-350000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 17:13:43+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 17:13:43+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,68000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 17:13:43+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,240000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 17:13:43+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,308000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 17:13:43+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,308000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 17:13:43+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-66000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 17:13:43+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,45172000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-181167000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-181167000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7458000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,189879000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5258000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10912000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10912000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-169665000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-169669000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-169669000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,82000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-71000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,11000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,11000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-158746000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,10368000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10368000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7474000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2110000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-25203000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5251000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5251000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-49000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-5000000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5049000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5049000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,79000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,528000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,607000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,607000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9693000.0
